Adenomyosis: the missed disease
Reproductive BioMedicine Online · 2025-04 · 50 (4) · 104837
DOI: 10.1016/j.rbmo.2025.104837 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive BioMedicine Online, 2025-04. Verfasst von Pietro Santulli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Santé, Faculté de Médicine Paris Centre, Université Paris-Cité, Paris, France.; Department of Gynecology Obstetrics II and Reproductive Me…. Hauptthemen laut MEDLINE: Adenomyosis. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Adenomyosis, a menstruation-related uterine disorder, refers to the presence of endometrial stroma and glands within the myometrium and is typically observed in reproductive-age women. The pathogenesis explaining the migration, persistence, proliferation and differentiation of ectopic endometrial cells includes a genetic and epigenetic background, an oestrogen/progesterone receptor imbalance and an inflammatory reaction driven by local immune dysfunction, along with fibrosis and neuroangiogenesis within the myometrium. In the past, it was thought that adenomyosis almost exclusively affected multiparous women after 40 years of age and the diagnosis was generally confirmed upon hysterectomy. Nowadays, using imaging techniques such as transvaginal ultrasonography and magnetic resonance imaging, adenomyosis is increasingly identified in young women with dysmenorrhoea, dyspareunia, abnormal uterine bleeding and heavy menstrual bleeding, and also in infertile patients. Furthermore, adenomyosis often coexists with other gynaecological conditions, such as endometriosis and uterine fibroids. Despite the improvement of non-invasive diagnostic tools, the awareness of the condition is still poor and the diagnosis is often missed, due also to a heterogeneity in clinical presentation and imaging criteria. In addition, medical and surgical management do not follow shared recommendations, even though adenomyosis requires a lifelong management plan, including pain and bleeding control, fertility preservation and pregnancy complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculté de Santé, Faculté de Médicine Paris Centre, Université Paris-Cité, Paris, France.; Department of Gynecology Obstetrics II and Reproductive Medicine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Univers…
- Department of Experimental, Clinical and Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.; Department of Maternal and Child Health, Careggi University Hospital, Florence, Italy.
- Department of Experimental, Clinical and Biomedical Sciences 'Mario Serio', University of Florence, Florence, Italy.; Department of Maternal and Child Health, Careggi University Hospital, Florence, Italy.. Electronic ad…
Zitieren
APA
Santulli, P., Vannuccini, S., Bourdon, M., Chapron, C., & Petraglia, F. (2025). Adenomyosis: the missed disease. Reproductive BioMedicine Online, 50(4), 104837. https://doi.org/10.1016/j.rbmo.2025.104837
Vancouver
Santulli P, Vannuccini S, Bourdon M, Chapron C, Petraglia F. Adenomyosis: the missed disease. Reproductive BioMedicine Online. 2025;50(4):104837. doi:10.1016/j.rbmo.2025.104837
BibTeX
@article{Santulli2025,
author = {Santulli, Pietro and Vannuccini, Silvia and Bourdon, Mathilde and Chapron, Charles and Petraglia, Felice},
title = {Adenomyosis: the missed disease},
journal = {Reproductive BioMedicine Online},
year = {2025},
volume = {50},
number = {4},
pages = {104837},
doi = {10.1016/j.rbmo.2025.104837}
}
EUVIMED